Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
117.42B | 119.01B | 104.78B | 97.34B | 97.97B | 80.99B | Gross Profit |
55.52B | 56.19B | 48.83B | 42.79B | 42.87B | 34.87B | EBIT |
21.97B | 22.07B | 18.20B | 15.97B | 17.96B | 13.94B | EBITDA |
31.41B | 24.94B | 21.73B | 23.75B | 25.94B | 21.42B | Net Income Common Stockholders |
11.42B | 10.78B | 8.65B | 11.40B | 11.80B | 9.53B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
42.62B | 44.90B | 58.58B | 47.12B | 51.56B | 54.70B | Total Assets |
198.81B | 192.02B | 212.75B | 187.26B | 189.27B | 179.00B | Total Debt |
67.19B | 64.52B | 86.72B | 71.50B | 78.15B | 81.22B | Net Debt |
24.57B | 19.62B | 29.06B | 24.38B | 26.59B | 26.51B | Total Liabilities |
90.86B | 89.04B | 112.35B | 94.53B | 103.81B | 102.51B | Stockholders Equity |
107.95B | 102.97B | 100.39B | 92.73B | 85.46B | 76.14B |
Cash Flow | Free Cash Flow | ||||
0.00 | 17.40B | 2.41B | 10.33B | 7.96B | 5.24B | Operating Cash Flow |
0.00 | 23.71B | 21.22B | 22.74B | 18.31B | 16.31B | Investing Cash Flow |
0.00 | -8.31B | -21.07B | -13.16B | -11.26B | -11.60B | Financing Cash Flow |
0.00 | -29.22B | 8.95B | -13.94B | -11.28B | 19.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥361.16B | 18.95 | 6.45% | 0.25% | 6.09% | -10.60% | |
75 Outperform | $278.05B | 9.21 | 7.73% | 3.40% | 3.67% | ― | |
73 Outperform | ¥244.55B | 9.65 | 5.38% | 0.02% | 5.89% | 11.92% | |
73 Outperform | $286.17B | 11.40 | 7.16% | 4.82% | 10.04% | -13.43% | |
70 Outperform | ¥338.55B | 30.80 | 5.04% | 13.59% | 24.68% | ||
66 Neutral | $344.70B | 10.11 | 13.00% | 2.55% | 4.72% | -30.40% | |
51 Neutral | $2.04B | -1.21 | -21.10% | 3.95% | 2.90% | -30.45% |
Taiyo Holdings Co., Ltd., a company listed on the Prime Market of the Tokyo Stock Exchange, has announced the finalization of the details regarding the members and working groups of its newly established 2030 Committee. This committee aims to enhance corporate value and secure shareholders’ interests over the medium to long term by ensuring objectivity and transparency in its discussions.
Taiyo Holdings Co., Ltd. has received acquisition proposals from multiple private equity funds aiming to take the company private, though no official decision has been made. To enhance corporate value and ensure shareholder interests, Taiyo Holdings has formed a special committee and established a ‘2030 Committee’ to evaluate future initiatives and address management challenges.
Taiyo Holdings has announced the establishment of a ‘2030 Committee’ to enhance corporate value and ensure transparency and objectivity in its management strategies. This committee will include external experts and will focus on evaluating and recommending capital policies, growth strategies, and governance structures, with an interim report expected by August 2025.
Taiyo Holdings’ Board of Directors has decided to oppose the shareholder proposals submitted by Oasis Japan Strategic Fund Y Ltd. for the upcoming General Shareholders’ Meeting. The proposals included the dismissal of two board directors, including the company’s President and CEO, Eiji Sato. This decision reflects the board’s stance on maintaining its current leadership structure, which may impact stakeholder confidence and influence the company’s governance dynamics.
Taiyo Holdings Co., Ltd. has announced its candidates for the Board of Directors, which will be presented at the upcoming 79th Ordinary General Shareholders’ Meeting in June 2025. The company is reappointing key figures such as Eiji Sato as President and CEO and introducing new independent directors, signaling a strategic move to strengthen its governance and oversight. This reshuffle may impact the company’s strategic direction and reassure stakeholders of its commitment to robust corporate governance.
Taiyo Holdings Co., Ltd. has announced a proposal to reduce its capital legal reserve and retained legal reserve to improve its distributable amount and maintain a flexible capital policy. This decision, which involves transferring the full amount of these reductions to other capital surplus and retained earnings, is expected to have no impact on the company’s net assets or operating results.
Taiyo Holdings Co., Ltd. has announced a year-end dividend of 150 yen per share for the fiscal year ended March 2025, as resolved by its Board of Directors. This decision aligns with the company’s policy of returning profits to shareholders, aiming for a consolidated total payout ratio of 100% until the fiscal year ending March 2028. The dividend reflects a significant increase from the previous year’s 42 yen per share, indicating the company’s commitment to shareholder returns and its strategic financial management.
Taiyo Holdings Co., Ltd. announced several key personnel changes during its Board of Directors meeting on April 30, 2025. These changes, effective in June and July 2025, involve senior positions within its subsidiaries, including Taiyo Pharma Co., Ltd. and Taiyo Fine Chemicals Co., Ltd. These strategic shifts are expected to enhance the company’s operational efficiency and strengthen its position in the medical and pharmaceutical sectors.
Taiyo Holdings Co., Ltd. has released its consolidated financial results for the fiscal year ending March 31, 2025. The announcement highlights the company’s diverse business segments, including ICT, fine chemicals, energy, and food. This financial disclosure may impact stakeholders by providing insights into the company’s operational performance and strategic positioning in its respective industries.
Taiyo Holdings Co., Ltd. has announced the recognition of extraordinary losses on its non-consolidated financial statements for the fiscal years ending March 31, 2024, and March 31, 2025. These losses, amounting to 4,784 million yen and 1,863 million yen respectively, are attributed to provisions for doubtful accounts related to loans to subsidiaries, including TAIYO Pharma Co., Ltd., which have experienced performance deterioration. However, these losses do not impact the consolidated financial statements, ensuring no direct effect on the overall financial health of the company.
Taiyo Holdings Co., Ltd. reported a significant increase in its financial performance for the fiscal year ending March 31, 2025, with net sales rising by 13.6% and operating income by 21.2%. The company also announced a substantial increase in dividends, reflecting strong profitability and a positive outlook for stakeholders.
Taiyo Holdings Co., Ltd. has announced a significant change in its major shareholders as of March 25, 2025. Oasis Management Company Ltd. increased its voting rights from 8.34% to 11.01%, reflecting a substantial rise in its shareholding. This change could potentially impact Taiyo Holdings’ operations and influence its strategic decisions, although the company has not indicated any immediate effects on its future outlook.
Taiyo Holdings Co., Ltd. has announced a change in its shareholder return policy, aiming to increase the year-end dividend for the fiscal year ended March 2025. The company plans to achieve a consolidated total payout ratio of 100% by the fiscal year ending March 2028, reflecting its commitment to improving return on equity and adapting to changes in the management environment.
Taiyo Holdings Co., Ltd. announced a revision of its full-year earnings forecast for the fiscal year ended March 31, 2025, due to the recognition of extraordinary losses amounting to 7,010 million yen. These losses were attributed to impairment in the sales rights of its subsidiary, TAIYO Pharma Co., Ltd., driven by factors such as yen weakness, inflation, and changes in the market environment. Despite these challenges, Taiyo Holdings has decided to increase its year-end dividend from 40 yen to 150 yen per share, reflecting its commitment to returning profits to shareholders and maintaining a strong Dividend on Equity ratio.